ResearcherTohoku UniversityNo recent work listed
Norihiko Sugisawa
Matched on ORCID iD 0000-0003-1887-7268; OpenAlex author ID A5049733110. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: 2 papers
Papers 5
- Inhibition of pancreatic cancer-cell growth and metastasis in vivo by a pyrazole compound characterized as a cell-migration inhibitor by an in vitro chemotaxis… Co-author DOI 10.1016/j.biopha.2022.113733↗
- High Incidence of Lymph-node Metastasis in a Pancreatic-cancer Patient-derived Orthotopic Xenograft (PDOX) NOG-Mouse Model. Co-author DOI 10.21873/anticanres.15532↗
- Triple-Methyl Blockade With Recombinant Methioninase, Cycloleucine, and Azacitidine Arrests a Pancreatic Cancer Patient-Derived Orthotopic Xenograft Model. Co-author DOI 10.1097/mpa.0000000000001709↗
- Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with agonist tigatuzumab in an orthotopic mouse… Co-author DOI 10.1016/j.canlet.2020.07.034↗
- Induction of Metastasis by Low-dose Gemcitabine in a Pancreatic Cancer Orthotopic Mouse Model: An Opposite Effect of Chemotherapy. Co-author DOI 10.21873/anticanres.13726↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Robert M. Hoffman · 5 shared papers, 2019–2022 · strength 0.56
- Paper High Incidence of Lymph-node Metastasis in a Pancreatic-cancer Patient-derived Orthotopic Xenograft (PDOX) NOG-Mouse Mo… DOI 10.21873/anticanres.15532↗
- Paper Triple-Methyl Blockade With Recombinant Methioninase, Cycloleucine, and Azacitidine Arrests a Pancreatic Cancer Patient… DOI 10.1097/mpa.0000000000001709↗
- Paper Inhibition of pancreatic cancer-cell growth and metastasis in vivo by a pyrazole compound characterized as a cell-migra… DOI 10.1016/j.biopha.2022.113733↗
- Michael Bouvet · 4 shared papers, 2019–2022 · strength 0.46
- Paper High Incidence of Lymph-node Metastasis in a Pancreatic-cancer Patient-derived Orthotopic Xenograft (PDOX) NOG-Mouse Mo… DOI 10.21873/anticanres.15532↗
- Paper Triple-Methyl Blockade With Recombinant Methioninase, Cycloleucine, and Azacitidine Arrests a Pancreatic Cancer Patient… DOI 10.1097/mpa.0000000000001709↗
- Paper Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with ag… DOI 10.1016/j.canlet.2020.07.034↗
- Kei Kawaguchi · 3 shared papers, 2019–2022 · strength 0.36
- Paper High Incidence of Lymph-node Metastasis in a Pancreatic-cancer Patient-derived Orthotopic Xenograft (PDOX) NOG-Mouse Mo… DOI 10.21873/anticanres.15532↗
- Paper Triple-Methyl Blockade With Recombinant Methioninase, Cycloleucine, and Azacitidine Arrests a Pancreatic Cancer Patient… DOI 10.1097/mpa.0000000000001709↗
- Paper Induction of Metastasis by Low-dose Gemcitabine in a Pancreatic Cancer Orthotopic Mouse Model: An Opposite Effect of Ch… DOI 10.21873/anticanres.13726↗
- Michiaki Unno · 3 shared papers, 2019–2022 · strength 0.36
- Paper High Incidence of Lymph-node Metastasis in a Pancreatic-cancer Patient-derived Orthotopic Xenograft (PDOX) NOG-Mouse Mo… DOI 10.21873/anticanres.15532↗
- Paper Triple-Methyl Blockade With Recombinant Methioninase, Cycloleucine, and Azacitidine Arrests a Pancreatic Cancer Patient… DOI 10.1097/mpa.0000000000001709↗
- Paper Induction of Metastasis by Low-dose Gemcitabine in a Pancreatic Cancer Orthotopic Mouse Model: An Opposite Effect of Ch… DOI 10.21873/anticanres.13726↗
- Kentaro Miyake · 3 shared papers, 2019–2022 · strength 0.34
- Paper High Incidence of Lymph-node Metastasis in a Pancreatic-cancer Patient-derived Orthotopic Xenograft (PDOX) NOG-Mouse Mo… DOI 10.21873/anticanres.15532↗
- Paper Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with ag… DOI 10.1016/j.canlet.2020.07.034↗
- Paper Induction of Metastasis by Low-dose Gemcitabine in a Pancreatic Cancer Orthotopic Mouse Model: An Opposite Effect of Ch… DOI 10.21873/anticanres.13726↗
- Hiroto Nishino · 2 shared papers, 2020–2021 · strength 0.21
- Paper Triple-Methyl Blockade With Recombinant Methioninase, Cycloleucine, and Azacitidine Arrests a Pancreatic Cancer Patient… DOI 10.1097/mpa.0000000000001709↗
- Paper Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with ag… DOI 10.1016/j.canlet.2020.07.034↗
- Jun Yamamoto · 2 shared papers, 2020–2021 · strength 0.21
- Paper Triple-Methyl Blockade With Recombinant Methioninase, Cycloleucine, and Azacitidine Arrests a Pancreatic Cancer Patient… DOI 10.1097/mpa.0000000000001709↗
- Paper Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with ag… DOI 10.1016/j.canlet.2020.07.034↗
- Sant P. Chawla · 2 shared papers, 2019–2020 · strength 0.18
- Paper Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with ag… DOI 10.1016/j.canlet.2020.07.034↗
- Paper Induction of Metastasis by Low-dose Gemcitabine in a Pancreatic Cancer Orthotopic Mouse Model: An Opposite Effect of Ch… DOI 10.21873/anticanres.13726↗
- Tomio Ueno · 1 shared paper, 2022 · strength 0.11
- 明 山内 · 1 shared paper, 2022 · strength 0.11
- Shuichiro Okamoto · 1 shared paper, 2022 · strength 0.11
- Masakiyo Sakaguchi · 1 shared paper, 2022 · strength 0.11
- Keisuke Hino · 1 shared paper, 2022 · strength 0.11
- Futoshi Kuribayashi · 1 shared paper, 2022 · strength 0.11
- Masahiro Yamamura · 1 shared paper, 2022 · strength 0.11
- Yuki Homma · 1 shared paper, 2020 · strength 0.09
- Itaru Endo · 1 shared paper, 2020 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.